GPCR

$42.21+0.76 (+1.83%)

Pre-Market$42.22+0.01 (+0.02%)· Last close May 1

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO